Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier
Ya Wei, Xue Xia, Hanmei Li, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1713-1730
Closed Access | Times Cited: 19

Showing 19 citing articles:

Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 12
Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting
Yiwei Zhang, Wei Xiao, Siqin He, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 42-51
Closed Access | Times Cited: 11
Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
Jun Yang, Yong Li, Shaoping Jiang, et al.
Exploration (2024)
Open Access | Times Cited: 10
Interactions between nanoparticles and pathological changes of vascular in Alzheimer’s disease
Ting Lei, Zixiao Yang, Hanmei Li, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115219-115219
Closed Access | Times Cited: 7
Nanotechnology in the diagnostic and therapy for Alzheimer's disease
Archna Panghal, S.J.S. Flora
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 3, pp. 130559-130559
Closed Access | Times Cited: 6
Advancements in device modelling and impedance analysis of a high performance disilicide (FeSi2)-based perovskite solar cell
A. Elmelouky, George G. Njema, Joshua K. Kibet
Renewable Energy (2025), pp. 122365-122365
Closed Access
Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer’s disease
Ya Wei, Xue Xia, Xiaorong Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer’s Disease
Peng Yang, Yixian Li, Kang Qian, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 14348-14366
Closed Access | Times Cited: 4
Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease
Tanvir Ahmed
European Journal of Neuroscience (2024) Vol. 59, Iss. 11, pp. 2915-2954
Closed Access | Times Cited: 3
Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator
Xue Xia, Ya Wei, Qianqian Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5464-5478
Open Access | Times Cited: 3
Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma
Vikram Vikram, Shobhit Kumar, Javed Ali, et al.
Assay and Drug Development Technologies (2024) Vol. 22, Iss. 2, pp. 73-85
Closed Access | Times Cited: 1
Cross-scale targeted remodeling of neurovascular and neurometabolic coupling in Alzheimer’s disease by natural self-assembled SIRT1 activator
Dongju Zhao, Fan Yang, Yining Liu, et al.
Nano Today (2024) Vol. 57, pp. 102340-102340
Closed Access | Times Cited: 1
Construction of an intranasal drug delivery system with hypothalamus‐targeting nanoparticles
Qianru Rao, Yujie Xu, Xiaorong Wang, et al.
SusMat (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 1
Surface Active Ligands for Enhanced Brain Targeting of Nanoparticles
A Prabakaran, Rajat Vashist, Sanchita Dhanchandra Sangave, et al.
(2024), pp. 241-262
Closed Access | Times Cited: 1
Extracellular vesicles‐based theranostics for neurodegenerative diseases
Han Zhao, Ling Zhu, Chen Wang, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 1
Brain targeted polymeric micelles as drug carriers for ischemic stroke treatment
Zirui Zhao, Huijia Song, M. Qi, et al.
Journal of drug targeting (2024), pp. 1-17
Closed Access
Virus-mimicking nanodrug active crossing of the blood-brain barrier via transcytosis against central nervous system leukemia
Xue Dong, Wei Wu, Chengling Zhang, et al.
Nano Today (2024) Vol. 59, pp. 102536-102536
Closed Access
Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood–brain-barrier and glioblastoma stem cells
Changhong Zhao, Xinshu Zhu, Huili Yang, et al.
Biomedical Materials (2024) Vol. 19, Iss. 5, pp. 055041-055041
Closed Access
Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases
Mei Zhao, Yuanyuan Lin, Yuteng Zeng, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 763-775
Closed Access
Page 1

Scroll to top